×
About 1,955 results

ALLMedicine™ Hirsutism Center

Research & Reviews  609 results

Spironolactone in Dermatology.
https://doi.org/10.1111/dth.15321
Dermatologic Therapy; Medina DAA, Cazarín J et. al.

Jan 18th, 2022 - Spironolactone is a drug, similar in structure to aldosterone and acts as an aldosterone receptor antagonist with an anti-androgenic effect. This drug has proven to be useful in several dermatological entities, however its use has not been well ex...

Antiandrogenic activity of Riboflavin 5'-phosphate (FMN) in 22Rv1 and LNCaP human prost...
https://doi.org/10.1016/j.ejphar.2022.174743
European Journal of Pharmacology; Choi YH, Kim J et. al.

Jan 10th, 2022 - The androgen receptor is a hormone activated transcription factor that regulates the development and maintenance of male characteristics and represents one of the most well-established drug targets, being implicated not only in prostate cancer but...

The effects of statins on hyperandrogenism in women with polycystic ovary syndrome: a s...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686603
Reproductive Biology and Endocrinology : RB&E; Chen J, Huang C et. al.

Dec 22nd, 2021 - Several clinical studies showed that statins were potential to treat polycystic ovary syndrome (PCOS). Through comprehensive search PubMed, EMBASE, the Web of Science, BIOSIS, the ClinialTrails.gov, and the Cochrane Library database up to 14 Feb 2...

A case report of ovarian granulosa cell tumor in patient with polycystic ovarian syndrome.
https://doi.org/10.1097/MD.0000000000028261
Medicine Kim YS, Lee JH

Dec 18th, 2021 - Granulosa cell tumors (GCTs) account for less than 2% of all ovarian malignancies and are the second most common ovarian sex cord stromal tumors after fibroma/thecomas.GCTs occur most frequently in postmenopausal women with a peak age of 50 to 55,...

Effects of Mixed of a Ketogenic Diet in Overweight and Obese Women with Polycystic Ovar...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656706
International Journal of Environmental Research and Publi... Cincione RI, Losavio F et. al.

Dec 11th, 2021 - Polycystic ovary syndrome (PCOS) is a commonly occurring endocrine disorder characterized by hirsutism, anovulation, and polycystic ovaries. Often comorbid with insulin resistance, dyslipidemia, and obesity, it also carries significant risk for th...

see more →

Guidelines  3 results

Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clin...
https://doi.org/10.1210/jc.2018-00241
The Journal of Clinical Endocrinology and Metabolism; Martin KA, Anderson RR et. al.

Mar 10th, 2018 - To update the "Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline," published by the Endocrine Society in 2008. The participants include an Endocrine Society-appointed task force of seven...

Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Andro...
https://doi.org/10.1093/humupd/dmr042
Human Reproduction Update; Escobar-Morreale HF, Carmina E et. al.

Nov 9th, 2011 - Hirsutism, defined by the presence of excessive terminal hair in androgen-sensitive areas of the female body, is one of the most common disorders in women during reproductive age. We conducted a systematic review and critical assessment of the ava...

Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clin...
https://doi.org/10.1210/jc.2007-2437
The Journal of Clinical Endocrinology and Metabolism; Martin KA, Chang RJ et. al.

Feb 7th, 2008 - Our objective was to develop clinical practice guidelines for the evaluation and treatment of hirsutism in premenopausal women. The Task Force was composed of a chair, selected by the Clinical Guidelines Subcommittee (CGS) of The Endocrine Society...

see more →

Drugs  25 results see all →

Clinicaltrials.gov  27 results

Androgen Excess as a Cause for Adipogenic Dysfunction in PCOS Women
https://clinicaltrials.gov/ct2/show/NCT01889199

Nov 9th, 2021 - Aim 1. Examine mechanisms of subcutaneous abdominal adipose (fat) development in normal-weight PCOS women vs. BMI- and age-matched normal (control) women. Subjects and clinical assessment: We will recruit 16 lean (18.5-25 kg/M2) PCOS subjects and ...

Growth Hormone Pretreatment in Poseidon Type IV Undergoing ICSI Using Minimal Induction Protocol: A Randomized Controlled Trial
https://clinicaltrials.gov/ct2/show/NCT05089344

Oct 22nd, 2021 - Patients are recruited from the attendee of the Infertility clinic and IVF unit in maternity hospital Ain shams university who are eligible for the trial. Procedure will be done by Prof . Dr Mostafa Fouad . and Lecturer Dr Ebtihal ElTaieb * Proper...

Ketogenic Diet in PCOS With Obesity and Insulin Resistance
https://clinicaltrials.gov/ct2/show/NCT04801173

Jun 4th, 2021 - Consecutive patients coming to the Endocrinology and Diabetes Clinic of the S.Orsola hospital in Bologna with the suspicion of PCOS, during the study period, will be eligible to participate. In the screening phase, patients from the clinic conform...

Metformin Versus Orlistat in Obese Polycystic Ovary Syndrome (PCOS) Patients
https://clinicaltrials.gov/ct2/show/NCT01003483

Apr 1st, 2021 - In a randomized clinical trial study, 80 obese women with BMI≥30, oligomenorrhae, hirsutism and presence of > 12 ovarian follicles (2-10mm diameter), were evaluated. In metformin group , metformin was administered for patients 1500 mg daily for th...

Does Spironolactone Normalize Sleep-wake Luteinizing Hormone Pulse Frequency in Pubertal Girls With Hyperandrogenism?
https://clinicaltrials.gov/ct2/show/NCT04723862

Jan 26th, 2021 - This is a randomized, placebo-controlled, double-blinded crossover study to test the following hypothesis: In mid- to late pubertal girls with hyperandrogenism, spironolactone (50 mg twice daily) for 2 weeks will reduce sleep-associated luteinizin...

see more →

News  108 results

FDA Approves Levoketoconazole for Cushing Syndrome
https://www.medscape.com/viewarticle/965989

Jan 4th, 2022 - The US Food and Drug Administration has approved levoketoconazole (Recorlev, Xeris Biopharma) for the treatment of endogenous hypercortisolemia in adults with Cushing syndrome for whom surgery is not possible or was not curative. Endogenous Cushin...

Polycystic Ovary Syndrome: It’s Not Just About Fertility
https://www.medscape.com/viewarticle/951631

May 21st, 2021 - Polycystic ovary syndrome, the most common endocrinopathy and most common cause of female infertility, affects 8%-13% of reproductive-aged women. PCOS has a profound impact on a woman’s life yet its diagnosis and management remain confusing despit...

Increased Risk of Meningioma With Cyproterone Acetate Use
https://www.medscape.com/viewarticle/945218

Feb 3rd, 2021 - New details confirm an increased risk of developing intracranial meningiomas after prolonged use of the hormonal product cyproterone acetate. Cyproterone acetate is a synthetic progestogen and potent anti-androgen that has been used in the treatme...

PCOS Linked to Postpartum Depression, Prenatal Mood
https://www.medscape.com/viewarticle/944507

Jan 22nd, 2021 - NEW YORK (Reuters Health) - Polycystic ovary syndrome (PCOS) is associated with postpartum depression, and prenatal depressed mood and anxiety mediate the association, highlighting the need for prenatal psychological screening in this population, ...

PCOS Tied to Risk for Cardiovascular Disease After Menopause
https://www.medscape.com/viewarticle/939402

Oct 19th, 2020 - Women with polycystic ovarian syndrome (PCOS) before menopause appear to have a greater risk of stroke, heart attack, and other cardiovascular events after menopause, according to findings presented Saturday, October 17, at the virtual American So...

see more →

Patient Education  10 results see all →